Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice

Japanese Journal of Cancer Research

Volumn 90, Issue 1, 1999, Pages 116-121

  Igarashi, Naoki ^a   Kubota, Tetsuro ^a   Otani, Yoshihide ^a   Matsuzaki, Shinjiro Wilson ^a   Watanabe, Masahiko ^a   Teramoto, Tatsuo ^a   Kumai, Koichiro ^a   Tamaki, Kazuhiko ^b   Tanzawa, Kazuhiko ^b   Kobayashi, Tomowo ^b   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Gastric cancer; MMP inhibitor; Nude mouse; Peritoneal dissemination; R 94138

Indexed keywords

CISPLATIN; GELATIN; MATRIX METALLOPROTEINASE INHIBITOR; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMATOUS PERITONITIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PERITONEUM; PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR CELL LINE; TUMOR XENOGRAFT; ZYMOGRAPHY;

EID: 0033006940     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00674.x     Document Type: Article

References (24)

1. Bunt, A. M., Hermans, J., Smit, V. T., van de Velde, C. J., Fleuren, G. J. and Bruijin, J. A. Surgical/pathological stage migration confounds comparison of gastric cancer survival rates between Japan and Western countries. J. Clin. Oncol., 13, 19-25 (1995).
2. Korenaga, D., Tsujitani, S. and Haraguchi, H. Long-term survival in Japanese patients with far advanced carcinoma of stomach. World J. Surg., 12, 236-240 (1988).
3. Okuyama, T., Endo, K., Maehara, Y., Baba, H., Oshiro, T., Adachi, Y. and Sugimachi, K. Continuous hyperthermic peritoneal perfusion with cisplatin in mice with peritoneal dissemination of B16 melanoma. Semin. Surg. Oncol., 10, 145-149 (1994).
4. Yonemura, Y., Fujimura, T., Nishimura, G., Falla, R., Sawa, T., Katayama, K., Tsugawa, K., Fushida, S., Miyazaki, I., Tanaka, M., Endou, Y. and Sasaki, T. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery, 119, 437-444 (1996).
5. Liotta, L. A., Steeg, P. S. and Sletler-Stevenson, W. Cancer metastasis and angiogenesis; an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
6. Otani, Y., Okazaki, I., Arai, M. Kameyama, K., Wada, N., Maruyama, K., Yoshino, K., Kitajima, M., Hosoda, Y. and Tsuchiya, M. Gene expression of interstitial collagenase (MMP-1) in gastrointestinal tract cancers. J. Gastroenterol., 29, 391-397 (1994).
7. Otani, Y. The collagenases activities, interstitial collagenase and Type IV collagenase in human stomach cancer; with special reference to local spreading and lymph node metastasis. Keio J. Med., 39, 159-167 (1990).
8. Sakurai, Y., Otani, Y., Kameyama, K., Hosoda, H., Okazaki, I., Kubota, T., Kumai, K. and Kitajima, M. Expression of interstitial collagenase (matrix metalloproteinase-1) in gastric cancer. Jpn. J. Cancer Res., 88, 401-406 (1997).
9. Tokuda, Y., Nagura, H., Maruo, K., Uemura, Y., Yoshimura, S., Tamaoki, K., Kondo, Y., Ogoshi, Y. and Mitomi, T. An immunohistochemical study of human gastric carcinoma in nude mice and athymic rats with special reference to secretory component production. Jpn. J. Cancer Clin., 27, 1605-1612 (1981) (in Japanese with English abstract).
10. Ochiai, A., Yasui, W. and Tahara, E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res. (Gann), 76, 1064-1071 (1985).
11. Tanzawa, K., Ishii, M., Ogita, T. and Shimada, K. Matlystatins, new inhibitors of type IV collagenases from Actinomadura atramentaria. J. Antibiot., 45, 1733-1737 (1992).
12. Tamaki, K., Kurihara, S., Oikawa, T., Tanzawa, K. and Sugimura, Y. Matlystatins, new inhibitors of type IV collagenases from Actinomadura atramentaria. J. Antibiot., 47, 1481-1492 (1994).
13. Tamaki, K., Tanzawa, K., Kurihara, S., Oikawa, T., Monma, S., Shimada, K. and Sugimura, Y. Synthesis and structure-activity relationships of gelatinase inhibitor derived from matlystatins. J. Pharm. Bull., 43, 1883-1893 (1995).
14. Sakurai, Y., Otani, Y., Kameyama, K., Igarashi, N., Kubota, T., Kumai, K. and Kitajima, M. The role of stromal cells in the expression of interstitial collagenase (matrix metalloproteinase-1) in the invasion of gastric cancer. J. Surg. Oncol., 66, 168-172 (1997).
15. Ogita, T., Sato, A., Enokita, R., Suzuki, K., Ishii, M., Negishi, T., Okazaki, T. and Tanzawa, K. Matlystatins, new inhibitor of type IV collagenases from Actinomadura atramentaria. J. Antibiot., 45, 1723-1732 (1982).
16. Watson, S. A., Moris, T. M., Robinson, G., Crimmin, M. J., Brown, P. D. and Hardcastle, J. D. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res., 55, 3629-3633 (1995).
17. Brown, P. Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv. Enzyme Regul., 35, 293-301 (1995).
18. Anderson, I., Shipp, M. and Docherty, A. Combination therapy including a gelatinase inhibition and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res., 56, 715-718 (1996).
19. Bramhall, S. R. The matrix metalloproteinases and their inhibitors in pancreatic cancer. Int. J. Pancreatol., 21, 1-12 (1997).
20. Drummond, A. H., Becker, P. and Bone, E. A. BB2516: an orally bioavailable matrix metalloproteinase inhibitor with efficacy in animal cancer models. Proc. Am. Assoc. Cancer Res., 36, 100 (1995).
21. Malfetano, J., Teng, N. and Moore, D. Marimastat, a novel matrix metalloproteinase inhibitor in patients with advanced cancer of ovary: a dose finding study. Proc. Am. Soc. Clin. Oncol., 15, 283a (1996).
22. Boasberg, P. and Harvaugh, B. Marimastat, a novel matrix metalloproteinase inhibitor in patients with hormone-refractory prostate cancer. Proc. Am. Soc. Clin. Oncol., 15, 258a (1996).
23. Zaknoen, S., Wolff, R., Cox, J., Marshall, J., Bordelon, T., Drunheller, A. and Rasmussen, H. Marimastat in advanced progressive colorectal cancer - a dose-finding study. Proc. Am. Soc. Clin. Oncol., 15, 273a (1996).
24. Tominaga, T., Abe, O., Asaishi, K., Abe, R., Enomoto, K., Kajiwara, T., Yoshida, M., Wada, T. and Nomura, Y. Phase II study of CGS16949A, a new aromatase inhibitor - a dose finding study. Jpn. J. Cancer Chemother., 21, 465-475 (1994) (in Japanese with English abstract).